Kestra Medical Technologies, Ltd.
KMTS
$17.71
-$0.29-1.61%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -20.92% | -- | -- | -- | |
| Total Depreciation and Amortization | -31.07% | -- | -- | -- | |
| Total Amortization of Deferred Charges | 129.51% | -- | -- | -- | |
| Total Other Non-Cash Items | 467.03% | -- | -- | -- | |
| Change in Net Operating Assets | -259.54% | -- | -- | -- | |
| Cash from Operations | -7.44% | -- | -- | -- | |
| Capital Expenditure | -88.52% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -0.70% | -- | -- | -- | |
| Cash from Investing | -90.60% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 37.87% | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 375.98% | -- | -- | -- | |
| Cash from Financing | 324.91% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 3,503.26% | -- | -- | -- | |